You are here

Perjeta

Roche’s fixed-dose subcutaneous combination of Perjeta and Herceptin comparable to intravenous formulations in people with HER2-positive breast cancer

Pharmaceutical Business Review

Fri, 12/13/19 - 12:20 pm

HER2+ breast cancer

SABCS: Roche's Perjeta builds case as add-on to Herceptin with new analysis

Fierce Pharma

Wed, 12/11/19 - 10:35 am

As ‘big three’ oncology meds lose sales, Roche looks to file subcutaneous breast cancer combo

Pharmaforum

Fri, 09/13/19 - 10:56 am

HER2-positive breast cancer

Roche snags another Perjeta combo nod, but will 'weak' data limit its use?

Fierce Pharma

Thu, 12/28/17 - 11:15 am

Drug developers face increasingly risky tightrope walk between top-line results and hard data

Endpoints

Tue, 08/15/17 - 10:57 am

drug development

clinical trials

late stage data

4 Reasons Why Roche Will Have the Best Growth in Big Pharma... and 1 Reason Why It Won't

Motley Fool

Wed, 04/12/17 - 10:33 am

HER-2 postive breast cancer

multiple sclerosis

Roche and Mylan settle a scrap over Herceptin, clearing path to a global launch of a knockoff drug

Endpoints

Mon, 03/13/17 - 10:13 am

Roche shares spike as PhIII breast cancer combo with Perjeta scores a success, Puma takes a beating

Endpoints

Thu, 03/2/17 - 10:41 am

clinical trials

Roche Has Aphinity For Perjeta Trial Success, But Not Puma

Seeking Alpha

Sun, 01/8/17 - 03:28 pm

Puma Biotechnology

A Look at Roche’s Potential Revenue Drivers

Market Realist

Tue, 07/26/16 - 11:21 am

Inside Roche’s Next Oncology Portfolio Drivers

Yahoo/Market Realist

Mon, 03/28/16 - 08:42 am

T-DM1. breast cancer

Biosimilars will cut top 10 vulnerable biologics almost in half by 2020: Morningstar

Fierce Pharma Marketing

Wed, 07/22/15 - 09:36 pm

Roche's Perjeta increases survival in late-stage breast cancer study

First Word Pharma

Mon, 09/29/14 - 08:53 am

Roche's breast cancer franchise keeps delivering, with huge jumps for Perjeta, Kadcyla

Fierce Pharma

Fri, 07/25/14 - 09:18 am

PDL Biopharma: Agreement With Genentech And Roche Is A Net Negative

Seeking Alpha

Tue, 02/4/14 - 09:58 am

Lucentis Xolair

PDL Biopharma says it settled Roche royalty fight

Yahoo/AP

Mon, 02/3/14 - 03:58 pm

FDA Approval Of Roche Cancer Drug Signals A New Paradigm

Pharmalot

Wed, 10/2/13 - 10:42 am

Roche breast cancer drug gets expanded U.S. pre-surgery approval

Reuters

Mon, 09/30/13 - 12:01 pm

Roche Perjeta Wins Panel Backing for Early Breast Cancer

Bloomberg

Fri, 09/13/13 - 08:42 am

advisory panels

FDA scientists back accelerated approval for Roche drug to treat early-stage breast cancer

Washington Post, DC

Tue, 09/10/13 - 10:39 am

Pages